MOUNTAIN VIEW, CA - NeuroPace Inc (NASDAQ:NPCE), a medical device company whose stock has seen significant volatility with a 78% surge over the past six months but a recent 8% decline in the past week,

Shares of NeuroPace dropped after the company said it would sell $65 million worth of shares at $10 apiece and use some proceeds to repurchase all stock owned by investor KCK. The stock was down 10% at 10.83 in premarket trading. Shares were trading around $15.46 this time a year ago.

NeuroPace (NPCE) announced that it intends to offer and sell, in an underwritten public offering, $65M of shares of its common stock. All of